Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Rentomojo Limited Announced it's Initial Public Offer (IPO) to open on Wednesday, September 09, 2026 Price Band has been fixed at ₹ 384 to ₹ 404 per Equity Share - Manipal Payment and Identity Solutions Limited Announced its Initial Public Offering (IPO) to Open on Wednesday, September 9, 2026 Price Band fixed at ₹322 to ₹339 per equity share of face value of ₹10 each - LCC Projects fixes IPO price band at Rs 139-146 per share; issue opens on Sep 9 - KARAMTARA ENGINEERING LIMITED ANNOUNCED ITS INITIAL PUBLIC OFFERING (IPO) OF EQUITY SHARES TO OPEN ON WEDNESDAY 09 SEPTEMBER 2026 Price Band fixed at ₹241 to ₹254 per equity share of face value of ₹10 each - LCC Projects Limited announces the price band for its IPO - Ola Electric's First Dealer Stores are Now Open across India - Prasol Chemicals Limited Announced its initial Public Offering (IPO) to Open on September 8 at Price Band of ₹643–₹676 - Asset Reconstruction Company (India) Limited Announced it's Initial Public Offering (IPO) to open on Wednesday, September 09, 2026 The Price Band of the Offer has been fixed from ₹ 132 per Equity Share of face value ₹ 10 each to ₹139per Equity Share of face value of ₹ 10 each - Veegaland Developers Limited’s IPO to Open on Thursday, September 10, 2026 Price Band fixed at ₹130 to ₹140 per equity share of face value of ₹10 each - Veegaland Developers Limited’s IPO to Open on Thursday, September 10, 2026 At the Price Band fixed at ₹130 to ₹140 per equity share of face value of ₹10 each

Cancer Survivors Meet 2025 Celebrates Strength, Hope, and Resilience at HCG ICS Khubchandani Cancer Centre


Mumbai, February 8, 2025 (GNI): HCG ICS Khubchandani Cancer Centre, Colaba, successfully hosted Cancer Survivors Meet 2025 on February 8, 2025, bringing together cancer survivors, their families, doctors, and support groups. The event aimed to recognize the journey of cancer warriors, provide guidance for life after treatment, and foster a strong support network for patients.
The gathering saw 15-20 cancer survivors accompanied by their families, engaging in interactive sessions led by renowned cancer specialists from HCG ICS Khubchandani Cancer Centre. Experts shared insights on post-treatment care and wellness, helping survivors navigate the next phase of their journey. Cancer warriors shared their experiences, inspiring others with their determination and willpower.
The event also included a felicitation ceremony for CPAA (Cancer Patients Aid Association) and Madat Charitable Trust, recognizing their invaluable support in providing financial assistance and resources to cancer patients.
Mr. George Alex, Regional Business Head – Maharashtra and Madhya Pradesh, HCG Hospitals, shared his thoughts on the occasion, stating “The Cancer Survivors Meet is a reflection of our commitment to providing not just advanced cancer care but also a strong support system for survivors. The strength and perseverance of cancer warriors inspire us all, and we are proud to stand with them on their journey.”
Dr. Sachin Trivedi, Director- Medical Oncology, HCG Cancer Center, emphasized the advancements in cancer care, stating: “The incidence of cancer is on the rise. However, the miracle of modern medicine has transformed the way we diagnose and treat cancer. With cutting-edge technology and a world-class talent pool, HCG is setting new standards in cancer care. Today was a demonstration of how we have been able to serve our patients. Our patients and their success stories keep us motivated to strive to improve the outcome for them.”
Dr. Prashant Pawar, Head & Neck Oncosurgeon, HCG Cancer Center, added: “This World Cancer Day, let us come together to raise awareness, encourage regular screenings, and support those affected by cancer. Remember, early detection saves lives.”
The event concluded with a sense of unity and encouragement, reinforcing HCG ICS Khubchandani Cancer Centre’s mission to support cancer patients beyond treatment.

About HCG ICS Khubchandani Cancer Centre Mumbai
HCG ICS Khubchandani Cancer Centre in Mumbai is a premier comprehensive cancer care hospital that combines expertise and innovation to provide exceptional cancer treatment. Our mission is to deliver high-quality, specialized care and help our patients achieve outstanding health outcomes. HCG was the first in Maharashtra to introduce the ground-breaking CyberKnife and Radixact TomoTherapy platforms, showcasing our ongoing commitment to leveraging state-of-the-art technology in cancer care.
Our specialised breast clinic provides a wide range of services, catering to preventive screenings, precise diagnostics, advanced treatments, and thorough follow-up care for breast cancer patients. Additionally, our breast clinic offers extensive support services, such as counselling, survivorship programs, and palliative care, aimed at addressing both the emotional and physical needs of patients as they navigate their breast cancer journey.ends GNI

Be the first to comment on "Cancer Survivors Meet 2025 Celebrates Strength, Hope, and Resilience at HCG ICS Khubchandani Cancer Centre"

Leave a comment

Your email address will not be published.


*